Lavender Callus Remover Gel

Manufacturer
SANSAR, LLC
Effective date
2025-05-09
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:00:51

Label at a glance#

ProductLavender Callus Remover
Active ingredientSALICYLIC ACID
Label structure10 sections

Indications and uses

for the removal of corns and calluses Relieves pain by removing corns and calluses

Dosage and administration

Soak feet for 10-15 minutes  Dry with a towel Wear Gloves, apply callus remover gel, leave for 10-15 minutes. Rinse of residue.

Label contents#

Full prescribing information#

Active ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic acid 12%

Purpose

OTC - PURPOSE SECTION

Corn and callus remover

Uses

INDICATIONS & USAGE SECTION

  • for the removal of corns and calluses
  • Relieves pain by removing corns and calluses

Warnings

WARNINGS SECTION

For external use only.

OTC - DO NOT USE SECTION

Do not use on Children under 2 without a Doctor's advice.

When using this product

OTC - WHEN USING SECTION

  • Wear gloves. Limit use to 20 minutes. Use cautiously with electric filing machines.
  • Avoid broken or non calloused skin. 
  • Avoid eye contact. Rinse for 15 minutes if contcat occurs. consult a physician if irritation persists.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of the reach of children. If swallowed, get medical help or contact a Poison Control Center immediately.

Directions 

DOSAGE & ADMINISTRATION SECTION

  • Soak feet for 10-15 minutes 
  • Dry with a towel
  • Wear Gloves, apply callus remover gel, leave for 10-15 minutes.
  • Rinse of residue.

Inactive Ingredients 

INACTIVE INGREDIENT SECTION

Distilled water, Alcohol ethoxylate, Potassium Hydroxide, Glycerin, Tetrasodium EDTA, Fragrance Essential Oil

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

lavendar-gellavendar-gel

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
2714099salicylic acid 12 % Topical GelPSN1
2714099salicylic acid 0.12 MG/MG Topical GelSCD1
2714099salicylic acid 12 % Topical GelSY1

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
83691-012-01Lavender Callus Remover236 mL in 1 BOTTLEGEL2361
83691-012-01Lavender Callus Remover1 in 1 CARTONGEL11
83691-012-02Lavender Callus Remover236 mL in 1 BOTTLEGEL2361
83691-012-02Lavender Callus Remover2 in 1 CARTONGEL21

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
83691-012LAVENDER CALLUS REMOVER (SALICYLIC ACID 12%) GEL [SANSAR, LLC]1Current NDC, 4 package rows20250514_4763bab3-631a-4fcf-8387-d7df4e89e0e4.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 8 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
83691-01283691-012-01, 83691-012-02

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 6 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Lavender Callus RemoverSALICYLIC ACID 12%SANSAR, LLC4763bab3-631a-4fcf-8387-d7df4e89e0e42025-05-09WarningsExact identifier
ndc (package): 83691-012-02
ndc (package): 83691-012-01
ndc (product): 83691-012
ndc11 (package): 83691001202
ndc11 (package): 83691001201
spl id: 7fe066f6-285e-4c55-ba18-64cc70f8d3c5
spl set id: 4763bab3-631a-4fcf-8387-d7df4e89e0e4

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.